The regulation of smooth muscle contraction and relaxation involves phosphorylation and dephosphorylation of regulatory proteins, particularly myosin. To elucidate the regulatory mechanisms, analyzing the phosphorylation signal transduction is crucial. Although a pharmacological approach with selective inhibitors is sensitive and a useful technique, it leads to speculation regarding a signaling pathway but does not pro- 
Introduction
Smooth muscle is found everywhere in the body -the walls of blood vessels, lymphatic vessels and hollow organs, and the ciliary muscle and iris of the eye. Although they basically have the same contractile and regulatory apparatuses in common, they respond differently to various stimuli to achieve specific effects at individual times.
The regulation of smooth muscle contraction and relaxation involves phosphorylation of regulatory proteins, including myosin (1-3), which generates contractile force. To study the regulatory signal transduction pathways, a variety of physiological and pharmacological techniques have been employed. Although pharmacological observations with the use of selective inhibitors can lead to speculation about the signal transduction pathways, they will not provide conclusive evidence due to their general lack of specificity.
By combining biochemical and pharmacological techniques, changes at a molecular level will be measurable, and thus conclusive evidence will be attainable. In this review, I will give examples of phosphorylation analysis, especially in small smooth muscles, which had been difficult to study biochemically.
And I will summarize our recent studies on a tiny blood vessel, the renal afferent arteriole.
Phosphorylation analysis in smooth muscles
It is widely accepted that the contraction of smooth muscle is primarily regulated by phosphorylation of myosin regulatory light chains (see reviews in Refs. (1-3) ). Actin-activated myosin ATPase and motor activities increase upon phosphorylation of its 20-kDa regulatory light chain (LC 20 ) at Ser19, resulting in contraction. These activities decrease when LC 20 is dephosphorylated, resulting in relaxation.
The level of LC 20 phosphorylation is determined by the balance between kinase and phosphatase activities. 
Highly sensitive phosphorylation analysis by Phos-tag SDS PAGE and 3-step western blotting
Recently, we successfully improved the sensitivity of the LC 20 phosphorylation analysis by combining Phos-tag SDS-PAGE with 3-step western blotting (17) .
Phos-tag SDS-PAGE provides separation of phosphorylated proteins from their unphosphorylated forms based on the number and position of the phosphorylated sites (18, 19) . Immobilized phosphate-affinity ligand (Phos-tag reagent) in a Laemmli SDS gel slows the migration of phosphorylated proteins due to binding to the ligand. Thus, the higher the stoichiometry of phosphorylation, the slower the migration rate through the gel ( Fig. 1 ) (13, 17) .
Three-step western blotting with the use of biotin-avidin binding significantly improved the sensitivity (17) . By optimizing the conditions of western blotting, we are able to detect as little as 0.5 pg LC 20 ( Fig. 2 ). This is sufficiently sensitive to quantify LC 20 in tiny smooth muscle tissues. For example, we were able to quantify LC 20 phosphorylation in rat cerebral artery (20, 21) and renal arterioles (see below and Refs. (17, 22) ).
Renal microvasculature
The renal afferent and efferent arterioles regulate the inflow and outflow resistance of the glomerulus, thereby controlling the pressure within the intervening glomerular capillaries (P GC ). P GC is a primary determinant of glomerular filtration rate (GFR) and must be maintained within precise limits for normal renal function and to protect against hypertensive injury. Angiotensin II (Ang II) is a renal vasoconstrictor that contributes to renal vascular resistance under normal physiological conditions and thus plays an important role in modulating renal hemodynamics (23) .
Bolus administration of Ang II elicits a transient constriction of the afferent arteriole (22, 24).
Endothelin-1 (ET-1) is also a potent renal vasoconstrictor. Unlike Ang II, ET-1 does not contribute to renal vascular resistance under normal physiologic conditions, but rather is implicated in abnormal renal vasoconstriction in a wide variety of pathologic states (25) (26) (27) . Bolus administration of ET-1 elicits longlasting constriction of the afferent arteriole (22, 24).
Although both Ang II and ET-1 are potent renal vasoconstrictors, the nature of renal vascular tone induced by these two agents is qualitatively different (22). In order to address the molecular determinants underlying these differences, biochemical analysis is essential.
The renal afferent arteriole is too small to detect molecular changes with conventional biochemical techniques. The isolated afferent arteriole is approximately one-tenth the size of a human eyelash (10-20 μm in diameter) and consists of < 100 smooth muscle cells on average. It contains ~50 pg (2.5 fmol) of LC 20 , well below the limit of detection of conventional assays (300 pg or 15 fmol) (16) .
By utilizing the newly developed Phos-tag electrophoresis and highly sensitive 3-step western blotting as described above, we successfully measured LC 20 phosphorylation in isolated afferent arterioles and were able to address the question whether Ang II and ET-1 activate distinct signaling pathways, resulting in different contractile responses (22).
Myosin LC 20 phosphorylation in the renal microvasculature
We isolated afferent arterioles from agarose-supported rat kidney (17, 22) . In brief, the left kidney of anesthetized rats was perfused in vivo with warmed Ca 2+ -free medium containing agarose. After the kidney was excised, it was chilled to solidify the agarose. The solidified agarose mimics the intraluminal pressure and thus allows the arterioles to maintain their physiological functions. Cortical slices were then treated with collagenase and dispase to separate microvessels from tubules. Individual arterioles were isolated and collected by using a dual-pipette micromanipulator. With this technique, we were able to measure molecular changes in afferent arterioles without contamination with tubules and other types of vessels.
Ang II induced exclusively monophosphorylation of LC 20 at Ser19. ET-1, on the other hand, induced not only monophosphorylation of LC 20 , but also diphosphorylation of LC 20 (Fig. 3) . The second phosphorylation site in ET-1-treated afferent arterioles was identified as Thr18 by western blotting with a diphosphorylationspecific antibody that recognizes LC 20 only when phosphorylated at both Ser19 and Thr18 (22). The diphosphorylation of LC 20 at Ser19 and Thr18 in response to ET-1 treatment was confirmed by proximity ligation assay (Fig. 4) , which provides higher sensitivity, specificity, and signal-to-noise ratio than regular immunostaining (28) . When stained with pan anti-LC 20 The observation that ET-1-induced constriction was relatively refractory to Ca 2+ channel blockade (22) is also consistent with the involvement of Ca 2+ -independent kinases -ZIPK and/or ILK.
Role of LC 20 diphosphorylation in the renal microvasculature
As it was reviewed previously (31, 32) , diphosphorylation of LC 20 was first demonstrated in vitro by high concentrations of MLCK (33) . The additional phosphorylation at Thr18 increased actomyosin MgATPase activity, but not actin-filament velocity in the in vitro motility assay (33) (34) (35) (36) (37) . Although LC 20 diphosphorylation has been associated with pathophysiological conditions involving smooth muscle hypercontractility (38) (39) (40) (41) (42) (43) , the mechanism whereby LC 20 diphosphorylation causes abnormal contraction remains controversial.
It has been proposed recently that the functional effect of LC 20 diphosphorylation is to reduce the dephosphorylation rate and thus to slow smooth muscle relaxation (44) . Based on this, we hypothesized that We concluded, therefore, that LC 20 diphosphorylation via ET B receptor activation contributes, at least in part, to the prolonged contraction induced by ET-1 in the renal afferent arteriole (Fig. 5) . Considering that ET-1 
Conclusions
In this review, I have provided an example of highly sensitive phosphorylation analysis that is capable of measuring phosphorylation in tiny tissue samples. By combining this biochemical approach with physiological, pharmacological and immunocytochemical approaches, we will be able to evaluate physiological events at a molecular level. As I showed in this review, Phos-tag based phosphorylation analysis, combined with proximity ligation assay, is suitable for studying micro-samples with high sensitivity. 
